Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725251 | SCV000335299 | uncertain significance | not provided | 2015-09-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000312083 | SCV000730774 | likely benign | not specified | 2017-06-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001088389 | SCV001002916 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338833 | SCV002641246 | likely benign | Cardiovascular phenotype | 2019-12-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000725251 | SCV003820188 | uncertain significance | not provided | 2019-06-28 | criteria provided, single submitter | clinical testing |